PREZISTA

Janssen Products LP🇺🇸 United States

FDA Page

Effective Date: Aug 15, 2023
Approval ID: 814301f9-c990-46a5-b481-2879a521a16f
Products: 5 registered
Version: 56

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PREZISTA safely and effectively. See Full Prescribing Information for PREZISTA. PREZISTA (darunavir) oral suspension PREZISTA (darunavir) tablet, for oral use Initial U.S. Approval: 2006

Quick Stats

Total Products5

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.